K.J. Harrison & Partners Inc - CLARUS THERAPEUTICS HLDNGS I ownership

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 21 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
K.J. Harrison & Partners Inc ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$1,000
-50.0%
13,0000.0%0.00%
Q1 2022$2,000
-50.0%
13,0000.0%0.00%
-100.0%
Q4 2021$4,000
-60.0%
13,0000.0%0.00%0.0%
Q3 2021$10,00013,0000.00%
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q4 2021
NameSharesValueWeighting ↓
LMR Partners LLP 229,750$342,0000.00%
Yakira Capital Management, Inc. 127,497$19,0000.00%
Bulldog Investors, LLP 42,601$6,0000.00%
CVI Holdings, LLC 247,578$36,0000.00%
ARISTEIA CAPITAL, L.L.C. 223,135$34,0000.00%
Context Capital Management, LLC 62,175$9,0000.00%
MARSHALL WACE, LLP 250,000$373,0000.00%
MIZUHO SECURITIES USA LLC 25,000$4,0000.00%
Tower Research Capital LLC (TRC) 91$00.00%
Virtu Financial LLC 13,479$2,0000.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders